Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
Frequently asked questions
What sector does Myrexis Inc Cmn Stk (MYRX) operate in?
Myrexis Inc Cmn Stk belongs to the Healthcare sector and operates in the Shell Companies industry.
What is Myrexis Inc Cmn Stk (MYRX) current stock price?
As of the latest data, Myrexis Inc Cmn Stk stock price is $0.00, with a previous close of $0.00.
What is Myrexis Inc Cmn Stk (MYRX) current market capitalization?
Myrexis Inc Cmn Stk market cap is approximately 27.58 thousand.
Does Myrexis Inc Cmn Stk (MYRX) pay dividends?
No. Myrexis Inc Cmn Stk does not pay a dividend.
What is Myrexis Inc Cmn Stk (MYRX) beta (volatility) score?
Myrexis Inc Cmn Stk has a beta of 2.995, indicating very high volatility compared to the market.